|
G |
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
EXP |
[Bortezomib co-treated with N,N-dimethylsphingosine] results in decreased expression of ABL1 protein |
CTD |
PMID:21195056 |
|
NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,043...130,887,675
|
|
G |
ASAH2 |
N-acylsphingosine amidohydrolase 2 |
multiple interactions |
EXP |
N,N-dimethylsphingosine inhibits the reaction [ASAH2 protein results in increased expression of BCL2 protein] |
CTD |
PMID:15498114 |
|
NCBI chr10:50,184,861...50,251,516
Ensembl chr10:50,182,778...50,279,720
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
N,N-dimethylsphingosine inhibits the reaction [ASAH2 protein results in increased expression of BCL2 protein] |
CTD |
PMID:15498114 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
C5 |
complement C5 |
multiple interactions |
EXP |
N,N-dimethylsphingosine inhibits the reaction [C5 protein results in increased activity of RELA protein] |
CTD |
PMID:19284563 |
|
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
[Bortezomib co-treated with N,N-dimethylsphingosine] results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:21195056 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions |
ISO |
N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased expression of FN1 protein] |
CTD |
PMID:21998146 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions |
EXP |
[Bortezomib co-treated with N,N-dimethylsphingosine] results in decreased expression of MCL1 protein |
CTD |
PMID:21195056 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[Bortezomib co-treated with N,N-dimethylsphingosine] results in increased cleavage of PARP1 protein |
CTD |
PMID:21195056 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
N,N-dimethylsphingosine inhibits the reaction [C5 protein results in increased activity of RELA protein] |
CTD |
PMID:19284563 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SPHK1 |
sphingosine kinase 1 |
decreases activity decreases expression multiple interactions |
EXP ISO |
N,N-dimethylsphingosine results in decreased activity of SPHK1 protein N,N-dimethylsphingosine results in decreased expression of SPHK1 protein N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased activity of SPHK1 protein] |
CTD |
PMID:17065523 PMID:19284563 PMID:21195056 PMID:21998146 |
|
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases transport |
EXP |
ABCB1 protein results in increased transport of N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine |
CTD |
PMID:21436125 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of ABCB1 |
CTD |
PMID:11573427 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein]; N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein N-acetylsphingosine results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:12640124 PMID:16215670 PMID:21821001 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
BAD |
BCL2 associated agonist of cell death |
multiple interactions decreases phosphorylation |
EXP |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of BAD protein] |
CTD |
PMID:24420784 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP |
N-acetylsphingosine results in increased expression of BAX mRNA N-acetylsphingosine promotes the reaction [Acetaminophen results in increased expression of BAX protein] |
CTD |
PMID:24420784 PMID:33959992 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
EXP |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 mRNA]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 protein]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 protein] N-acetylsphingosine results in decreased expression of BCL2 mRNA; N-acetylsphingosine results in decreased expression of BCL2 protein |
CTD |
PMID:9295281 PMID:16215670 PMID:24420784 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions increases degradation |
EXP |
LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein] |
CTD |
PMID:21821001 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BIRC2 |
baculoviral IAP repeat containing 2 |
decreases expression |
EXP |
[C2-ceramide cotreated with paclitaxel] decreases expression of BIRC2 mRNA in non-small cell lung cancer cells |
RGD |
PMID:20624405 |
RGD:152999014 |
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
|
|
G |
BIRC3 |
baculoviral IAP repeat containing 3 |
decreases expression |
EXP |
[C2-ceramide cotreated with paclitaxel] decreases expression of BIRC3 mRNA in non-small cell lung cancer cells |
RGD |
PMID:20624405 |
RGD:152999014 |
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein]; N-acetylsphingosine promotes the reaction [Acetaminophen results in increased expression of CASP3 protein]; N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein N-acetylsphingosine results in increased activity of CASP3 protein |
CTD |
PMID:10919278 PMID:16215670 PMID:21259059 PMID:28052715 PMID:33959992 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAV1 |
caveolin 1 |
multiple interactions |
EXP |
N-acetylsphingosine inhibits the reaction [CAV1 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:12640124 |
|
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
multiple interactions decreases localization |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein]; N-acetylsphingosine inhibits the reaction [oltipraz results in increased localization of CEBPB protein] |
CTD |
PMID:15319326 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CFTR |
CF transmembrane conductance regulator |
increases activity |
EXP |
N-acetylsphingosine results in increased activity of CFTR protein |
CTD |
PMID:15474513 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
|
|
G |
CLDN4 |
claudin 4 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of CLDN4 mRNA; N-acetylsphingosine results in decreased expression of CLDN4 protein |
CTD |
PMID:28052715 |
|
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
|
|
G |
CLK1 |
CDC like kinase 1 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of CLK1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 2:200,853,009...200,864,658
Ensembl chr 2:200,853,009...200,864,691
|
|
G |
CTSD |
cathepsin D |
increases secretion |
ISO |
N-acetylsphingosine results in increased secretion of CTSD protein |
CTD |
PMID:15040013 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
DAPK1 |
death associated protein kinase 1 |
increases activity |
EXP ISO |
N-acetylsphingosine results in increased activity of DAPK1 protein |
CTD |
PMID:17087515 |
|
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
|
|
G |
DFFB |
DNA fragmentation factor subunit beta |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of DFFB protein |
CTD |
PMID:15040013 |
|
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
|
|
G |
DNM1L |
dynamin 1 like |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of DNM1L protein |
CTD |
PMID:18006463 |
|
NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
N-acetylsphingosine inhibits the reaction [EGF protein results in increased abundance of Diglycerides] |
CTD |
PMID:11082532 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions increases expression |
EXP |
N-acetylsphingosine promotes the reaction [IL1B protein results in increased expression of F3 protein] N-acetylsphingosine results in increased expression of F3 protein |
CTD |
PMID:27556861 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FIS1 |
fission, mitochondrial 1 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of FIS1 protein |
CTD |
PMID:18006463 |
|
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased activity of GOT1 protein] |
CTD |
PMID:33959992 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased activity of GPT protein] |
CTD |
PMID:33959992 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX3 |
glutathione peroxidase 3 |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased activity of GPX3 protein] |
CTD |
PMID:33959992 |
|
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
|
|
G |
GSK3A |
glycogen synthase kinase 3 alpha |
decreases phosphorylation |
EXP |
N-acetylsphingosine results in decreased phosphorylation of GSK3A protein |
CTD |
PMID:21821001 |
|
NCBI chr19:42,230,190...42,242,602
Ensembl chr19:42,226,225...42,242,625
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
decreases phosphorylation decreases expression multiple interactions |
EXP |
N-acetylsphingosine results in decreased phosphorylation of GSK3B protein N-acetylsphingosine results in decreased expression of GSK3B protein modified form GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein] |
CTD |
PMID:21821001 PMID:24420784 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of and results in increased secretion of GSTA1 protein]; N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of GSTA1 mRNA]; N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of GSTA1 protein] |
CTD |
PMID:31385618 PMID:33959992 |
|
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
|
|
G |
GSTA2 |
glutathione S-transferase alpha 2 |
multiple interactions decreases expression |
ISO |
N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GSTA2 protein]; N-acetylsphingosine inhibits the reaction [oltipraz results in increased expression of GSTA2 protein] N-acetylsphingosine results in decreased expression of GSTA2 protein |
CTD |
PMID:15155840 PMID:15319326 |
|
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
|
|
G |
GSTA5 |
glutathione S-transferase alpha 5 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of GSTA5 protein |
CTD |
PMID:15155840 |
|
NCBI chr 6:52,831,692...52,846,245
Ensembl chr 6:52,831,655...52,840,843
|
|
G |
HMOX1 |
heme oxygenase 1 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of HMOX1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF1A |
HNF1 homeobox A |
multiple interactions decreases ubiquitination |
ISO EXP |
N-acetylsphingosine results in decreased expression of and results in decreased activity of HNF1A protein N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of HNF1A mRNA]; N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased expression of HNF1A protein] N-acetylsphingosine results in decreased ubiquitination of HNF1A protein |
CTD |
PMID:15155840 PMID:31385618 PMID:33959992 |
|
NCBI chr12:120,978,543...121,002,512
Ensembl chr12:120,978,543...121,002,512
|
|
G |
HRK |
harakiri, BCL2 interacting protein |
increases expression multiple interactions |
EXP |
N-acetylsphingosine results in increased expression of HRK mRNA N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [N-acetylsphingosine results in increased expression of HRK mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in increased expression of HRK mRNA] |
CTD |
PMID:24420784 |
|
NCBI chr12:116,856,144...116,881,441
Ensembl chr12:116,856,144...116,881,441
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of ID2 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
IL16 |
interleukin 16 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of IL16 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [IL1B protein results in increased expression of F3 protein] |
CTD |
PMID:27556861 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased phosphorylation of JUN protein] |
CTD |
PMID:33959992 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KDR |
kinase insert domain receptor |
multiple interactions |
ISO EXP |
N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of KDR protein sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA] |
CTD |
PMID:15313899 PMID:15741222 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
KLF6 |
KLF transcription factor 6 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of KLF6 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
|
|
G |
LGALS3 |
galectin 3 |
multiple interactions increases expression decreases response to substance |
EXP |
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]; GSK3B mutant form inhibits the reaction [N-acetylsphingosine results in increased expression of LGALS3 protein]; LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein]; LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of MCL1 protein] LGALS3 results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:21821001 |
|
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
EXP |
N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein; TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein] |
CTD |
PMID:18270325 |
|
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of MAPK1 protein |
CTD |
PMID:10700234 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of MAPK3 protein |
CTD |
PMID:10700234 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:33959992 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP ISO |
N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein; TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:18270325 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions increases degradation |
EXP |
LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of MCL1 protein] |
CTD |
PMID:21821001 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MDM2 |
MDM2 proto-oncogene |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MDM2 mRNA; N-acetylsphingosine results in decreased expression of MDM2 protein |
CTD |
PMID:18206046 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MFN2 |
mitofusin 2 |
decreases response to substance |
ISO |
MFN2 protein results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:18006463 |
|
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
|
|
G |
MIR15B |
microRNA 15b |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIR15B mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 3:160,404,588...160,404,685
Ensembl chr 3:160,404,588...160,404,685
|
|
G |
MIR20A |
microRNA 20a |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIR20A mRNA |
CTD |
PMID:20145152 |
|
NCBI chr13:91,351,065...91,351,135
Ensembl chr13:91,351,065...91,351,135
|
|
G |
MIR25 |
microRNA 25 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIR25 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 7:100,093,560...100,093,643
Ensembl chr 7:100,093,560...100,093,643
|
|
G |
MIR622 |
microRNA 622 |
increases response to substance decreases expression |
EXP |
MIR622 mRNA results in increased susceptibility to N-acetylsphingosine N-acetylsphingosine results in decreased expression of MIR622 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr13:90,231,182...90,231,277
Ensembl chr13:90,231,182...90,231,277
|
|
G |
MIR629 |
microRNA 629 |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of MIR629 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468
|
|
G |
MIR630 |
microRNA 630 |
increases response to substance increases expression |
EXP |
MIR630 mRNA results in increased susceptibility to N-acetylsphingosine N-acetylsphingosine results in increased expression of MIR630 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr15:72,587,217...72,587,313
Ensembl chr15:72,587,217...72,587,313
|
|
G |
MIR663A |
microRNA 663a |
increases expression |
EXP |
N-acetylsphingosine results in increased expression of MIR663A mRNA |
CTD |
PMID:20145152 |
|
NCBI chr20:26,208,186...26,208,278
Ensembl chr20:26,208,186...26,208,278
|
|
G |
MIR93 |
microRNA 93 |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIR93 mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847
|
|
G |
MIRLET7B |
microRNA let-7b |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIRLET7B mRNA |
CTD |
PMID:20145152 |
|
NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768
|
|
G |
MIRLET7D |
microRNA let-7d |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIRLET7D mRNA |
CTD |
PMID:20145152 |
|
NCBI chr 9:94,178,834...94,178,920
Ensembl chr 9:94,178,834...94,178,920
|
|
G |
MIRLET7E |
microRNA let-7e |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIRLET7E mRNA |
CTD |
PMID:20145152 |
|
NCBI chr19:51,692,786...51,692,864
Ensembl chr19:51,692,786...51,692,864
|
|
G |
MIRLET7I |
microRNA let-7i |
decreases expression |
EXP |
N-acetylsphingosine results in decreased expression of MIRLET7I mRNA |
CTD |
PMID:20145152 |
|
NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases localization |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of NFE2L2 protein]; N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein] |
CTD |
PMID:15319326 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NGF |
nerve growth factor |
multiple interactions |
ISO |
N-acetylsphingosine affects the reaction [Glutathione affects the activity of NGF protein] |
CTD |
PMID:12381813 |
|
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
|
|
G |
NRP1 |
neuropilin 1 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
|
|
G |
NRP2 |
neuropilin 2 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr 2:205,682,501...205,798,131
Ensembl chr 2:205,681,990...205,798,133
|
|
G |
OCLN |
occludin |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of OCLN mRNA; N-acetylsphingosine results in decreased expression of OCLN protein |
CTD |
PMID:28052715 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
ODC1 |
ornithine decarboxylase 1 |
decreases activity |
EXP |
N-acetylsphingosine results in decreased activity of ODC1 protein |
CTD |
PMID:17521618 |
|
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases activity |
EXP |
N-acetylsphingosine results in increased activity of PARP1 protein |
CTD |
PMID:24420784 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PINK1 |
PTEN induced kinase 1 |
decreases response to substance |
ISO EXP |
PINK1 protein results in decreased susceptibility to N-acetylsphingosine |
CTD |
PMID:24792327 |
|
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
|
|
G |
PLAT |
plasminogen activator, tissue type |
multiple interactions |
EXP |
[N-acetylsphingosine results in increased abundance of Ceramides] which results in increased secretion of PLAT protein |
CTD |
PMID:11107162 |
|
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
multiple interactions increases degradation |
EXP |
BCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein] |
CTD |
PMID:16215670 |
|
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
increases activity |
ISO |
N-acetylsphingosine results in increased activity of RAF1 protein |
CTD |
PMID:10700234 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
affects activity |
EXP |
N-acetylsphingosine affects the activity of RELA protein |
CTD |
PMID:12853972 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RHOB |
ras homolog family member B |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of RHOB mRNA |
CTD |
PMID:18270325 |
|
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
|
|
G |
SERPINE1 |
serpin family E member 1 |
multiple interactions |
EXP |
[N-acetylsphingosine results in increased abundance of Ceramides] which results in decreased secretion of SERPINE1 protein |
CTD |
PMID:11107162 |
|
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
N-acetylsphingosine promotes the reaction [Acetaminophen results in decreased activity of SOD1 protein] |
CTD |
PMID:33959992 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
increases expression multiple interactions |
EXP ISO |
N-acetylsphingosine results in increased expression of SOD2 mRNA; N-acetylsphingosine results in increased expression of SOD2 protein Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of SOD2 protein] |
CTD |
PMID:9535218 PMID:10428046 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
STS |
steroid sulfatase |
multiple interactions |
EXP |
N-acetylsphingosine inhibits the reaction [Tretinoin results in increased activity of STS protein] |
CTD |
PMID:16178010 |
|
NCBI chr X:7,147,290...7,354,641
Ensembl chr X:7,147,237...7,804,358
|
|
G |
TFE3 |
transcription factor binding to IGHM enhancer 3 |
multiple interactions |
EXP |
N-acetylsphingosine results in decreased phosphorylation of and affects the localization of TFE3 protein |
CTD |
PMID:29945972 |
|
NCBI chr X:49,028,726...49,043,357
Ensembl chr X:49,028,726...49,043,410
|
|
G |
TGIF1 |
TGFB induced factor homeobox 1 |
increases expression |
ISO |
N-acetylsphingosine results in increased expression of TGIF1 mRNA |
CTD |
PMID:18270325 |
|
NCBI chr18:3,412,009...3,459,978
Ensembl chr18:3,411,608...3,459,978
|
|
G |
TJP1 |
tight junction protein 1 |
decreases expression |
ISO |
N-acetylsphingosine results in decreased expression of TJP1 mRNA; N-acetylsphingosine results in decreased expression of TJP1 protein |
CTD |
PMID:28052715 |
|
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 mRNA]; Acetylcysteine inhibits the reaction [N-acetylsphingosine results in increased expression of TP53 protein] N-acetylsphingosine results in increased expression of TP53 mRNA; N-acetylsphingosine results in increased expression of TP53 protein |
CTD |
PMID:9535218 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TXN |
thioredoxin |
decreases activity multiple interactions |
EXP |
N-acetylsphingosine results in decreased activity of TXN protein TXNIP affects the reaction [N-acetylsphingosine results in decreased activity of TXN protein] |
CTD |
PMID:18270325 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
TXNIP |
thioredoxin interacting protein |
increases expression multiple interactions |
EXP ISO |
N-acetylsphingosine results in increased expression of TXNIP protein N-acetylsphingosine results in increased expression of TXNIP mRNA; N-acetylsphingosine results in increased expression of TXNIP protein TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein]; TXNIP affects the reaction [N-acetylsphingosine results in decreased activity of TXN protein]; TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] |
CTD |
PMID:18270325 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
ISO |
N-acetylsphingosine results in decreased expression of and results in decreased secretion of VEGFA protein |
CTD |
PMID:15313899 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
ASAH2 |
N-acylsphingosine amidohydrolase 2 |
multiple interactions |
EXP |
ASAH2 protein inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:15946935 |
|
NCBI chr10:50,184,861...50,251,516
Ensembl chr10:50,182,778...50,279,720
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions increases expression |
ISO |
ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF4 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
|
|
G |
ATF6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
CS |
citrate synthase |
multiple interactions decreases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in decreased activity of CS protein; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in decreased activity of CS protein]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in decreased expression of CS mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of DDIT3 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of DDIT3 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of DDIT3 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of HSPA5 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of HSPA5 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases abundance |
EXP |
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [IL1B protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:27556861 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR1 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR1 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ITPR1 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
ITPR2 |
inositol 1,4,5-trisphosphate receptor type 2 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ITPR2 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ITPR2 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194
|
|
G |
LIPC |
lipase C, hepatic type |
multiple interactions |
ISO |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of N-palmitoylsphingosine |
CTD |
PMID:24777581 |
|
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
|
|
G |
LIPG |
lipase G, endothelial type |
multiple interactions |
ISO |
[LIPC gene mutant form co-treated with LIPG gene mutant form] results in increased abundance of N-palmitoylsphingosine |
CTD |
PMID:24777581 |
|
NCBI chr18:49,561,479...49,599,185
Ensembl chr18:49,560,699...49,599,185
|
|
G |
MFN2 |
mitofusin 2 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of MFN2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of MFN2 mRNA] N-palmitoylsphingosine results in increased expression of MFN2 mRNA |
CTD |
PMID:28223344 |
|
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
|
|
G |
PACS2 |
phosphofurin acidic cluster sorting protein 2 |
multiple interactions increases expression |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of PACS2 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of PACS2 mRNA] N-palmitoylsphingosine results in increased expression of PACS2 mRNA |
CTD |
PMID:28223344 |
|
NCBI chr14:105,300,774...105,398,147
Ensembl chr14:105,300,563...105,398,147
|
|
G |
PC |
pyruvate carboxylase |
multiple interactions |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased activity of PC protein; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased activity of PC protein] |
CTD |
PMID:28223344 |
|
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
|
|
G |
TNF |
tumor necrosis factor |
increases abundance multiple interactions |
ISO EXP |
TNF protein results in increased abundance of N-palmitoylsphingosine ASAH2 protein inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] Imipramine inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] |
CTD |
PMID:15946935 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VDAC1 |
voltage dependent anion channel 1 |
multiple interactions |
ISO |
[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of VDAC1 mRNA] |
CTD |
PMID:28223344 |
|
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
|
|
|
G |
CDC42 |
cell division cycle 42 |
multiple interactions |
ISO |
Sphingosine inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]]; Sphingosine inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]] |
CTD |
PMID:2153673 |
|
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
|
|
G |
CRH |
corticotropin releasing hormone |
multiple interactions |
ISO |
Sphingosine inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]] |
CTD |
PMID:2153673 |
|
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
increases expression |
EXP |
Sphingosine results in increased expression of CYP17A1 mRNA |
CTD |
PMID:15666826 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
TAT |
tyrosine aminotransferase |
multiple interactions |
ISO |
Sphingosine inhibits the reaction [Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]]; Sphingosine inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [Dexamethasone results in increased activity of TAT protein]]; Sphingosine inhibits the reaction [Ursodeoxycholic Acid promotes the reaction [Dexamethasone results in increased activity of TAT protein]] |
CTD |
PMID:9398635 |
|
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
|
|
G |
TERT |
telomerase reverse transcriptase |
affects activity |
EXP |
Sphingosine affects the activity of TERT protein |
CTD |
PMID:9434777 |
|
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
|
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions increases expression |
ISO |
sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of ACTA2 mRNA]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of ACTA2 protein] sphingosine 1-phosphate results in increased expression of ACTA2 mRNA; sphingosine 1-phosphate results in increased expression of ACTA2 protein |
CTD |
PMID:37169277 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
sphingosine 1-phosphate results in increased phosphorylation of and results in increased activity of AKT1 protein sphingosine 1-phosphate results in increased phosphorylation of AKT1 protein |
CTD |
PMID:15946935 PMID:16365044 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ATG5 |
autophagy related 5 |
multiple interactions increases expression |
ISO |
3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of ATG5 mRNA]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of ATG5 protein] sphingosine 1-phosphate results in increased expression of ATG5 mRNA; sphingosine 1-phosphate results in increased expression of ATG5 protein |
CTD |
PMID:37169277 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
EXP |
sphingosine 1-phosphate results in decreased expression of BAX mRNA sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] |
CTD |
PMID:24399507 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of BCL2 protein] |
CTD |
PMID:24399507 PMID:24420784 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BECN1 |
beclin 1 |
increases expression multiple interactions |
ISO |
sphingosine 1-phosphate results in increased expression of BECN1 mRNA; sphingosine 1-phosphate results in increased expression of BECN1 protein sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of BECN1 mRNA]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of BECN1 protein] |
CTD |
PMID:37169277 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of and results in increased cleavage of CASP1 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of CASP1 mRNA] |
CTD |
PMID:37169277 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CCN2 |
cellular communication network factor 2 |
increases expression |
ISO EXP |
sphingosine 1-phosphate results in increased expression of CCN2 mRNA |
CTD |
PMID:25690654 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
ISO |
3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of COL1A1 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of COL1A1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [sphingosine 1-phosphate results in increased expression of COL1A1 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of COL1A1 mRNA] sphingosine 1-phosphate results in increased expression of COL1A1 mRNA; sphingosine 1-phosphate results in increased expression of COL1A1 protein |
CTD |
PMID:37169277 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
increases phosphorylation multiple interactions |
EXP |
sphingosine 1-phosphate results in increased phosphorylation of CREB1 protein JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of CREB1 protein]; Suramin inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:18612546 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions increases expression |
EXP |
1-Butanol inhibits the reaction [sphingosine 1-phosphate results in increased expression of CXCL8 mRNA]; Dactinomycin inhibits the reaction [sphingosine 1-phosphate results in increased expression of CXCL8 mRNA]; Pertussis Toxin inhibits the reaction [sphingosine 1-phosphate results in increased expression of CXCL8 protein] sphingosine 1-phosphate results in increased expression of CXCL8 mRNA; sphingosine 1-phosphate results in increased expression of CXCL8 protein |
CTD |
PMID:12039947 PMID:19349368 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR1 |
C-X-C motif chemokine receptor 1 |
decreases expression |
EXP |
sphingosine 1-phosphate results in decreased expression of CXCR1 mRNA |
CTD |
PMID:16224106 |
|
NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of CYP17A1 mRNA |
CTD |
PMID:15666826 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
EGFR |
epidermal growth factor receptor |
increases phosphorylation multiple interactions |
EXP |
sphingosine 1-phosphate results in increased phosphorylation of EGFR protein JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of EGFR protein] |
CTD |
PMID:26518876 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
FN1 |
fibronectin 1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; 3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; 3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein; [sphingosine 1-phosphate results in increased activity of S1PR2 protein] which results in increased expression of FN1; Curcumin inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; SB 203580 inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of FN1 protein] |
CTD |
PMID:21998146 PMID:22406263 PMID:37169277 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
GNAQ |
G protein subunit alpha q |
multiple interactions increases expression |
EXP |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of GNAQ protein]; Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of GNAQ protein] |
CTD |
PMID:25980589 |
|
NCBI chr 9:77,716,097...78,031,811
Ensembl chr 9:77,716,097...78,031,811
|
|
G |
GSK3A |
glycogen synthase kinase 3 alpha |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of GSK3A protein]; Wortmannin inhibits the reaction [sphingosine 1-phosphate inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of GSK3A protein]] |
CTD |
PMID:25769802 |
|
NCBI chr19:42,230,190...42,242,602
Ensembl chr19:42,226,225...42,242,625
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
sphingosine 1-phosphate affects the reaction [beta-N-methylamino-L-alanine results in increased expression of GSK3B protein]; Wortmannin affects the reaction [sphingosine 1-phosphate affects the reaction [beta-N-methylamino-L-alanine results in increased expression of GSK3B protein]] |
CTD |
PMID:25769802 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
HGF |
hepatocyte growth factor |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of HGF mRNA |
CTD |
PMID:19349368 |
|
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
|
|
G |
HRK |
harakiri, BCL2 interacting protein |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HRK mRNA]; sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in increased expression of HRK mRNA] |
CTD |
PMID:24399507 PMID:24420784 |
|
NCBI chr12:116,856,144...116,881,441
Ensembl chr12:116,856,144...116,881,441
|
|
G |
HSF1 |
heat shock transcription factor 1 |
increases activity |
EXP |
sphingosine 1-phosphate results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
|
|
G |
IGF1 |
insulin like growth factor 1 |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of IGF1 mRNA |
CTD |
PMID:19349368 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
ISO |
3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL18 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL18 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of IL18 protein] |
CTD |
PMID:37169277 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL1B |
interleukin 1 beta |
increases secretion multiple interactions increases expression |
EXP |
sphingosine 1-phosphate results in increased secretion of IL1B protein Janus Kinase Inhibitors inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL1B mRNA]; Janus Kinase Inhibitors inhibits the reaction [sphingosine 1-phosphate results in increased secretion of IL1B protein]; S1PR1 protein affects the reaction [sphingosine 1-phosphate results in increased expression of IL1B mRNA]; STAT3 protein affects the reaction [sphingosine 1-phosphate results in increased expression of IL1B mRNA]; STAT3 protein affects the reaction [sphingosine 1-phosphate results in increased secretion of IL1B protein] |
CTD |
PMID:32401414 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of IL6 mRNA] |
CTD |
PMID:26518876 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
JAK2 |
Janus kinase 2 |
increases phosphorylation |
EXP |
sphingosine 1-phosphate results in increased phosphorylation of JAK2 protein |
CTD |
PMID:32401414 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
KDR |
kinase insert domain receptor |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of KDR mRNA]; sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of KDR mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
|
|
G |
LAMA3 |
laminin subunit alpha 3 |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of LAMA3 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222
|
|
G |
LAMB3 |
laminin subunit beta 3 |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of LAMB3 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
|
|
G |
LAMC2 |
laminin subunit gamma 2 |
increases expression |
EXP |
sphingosine 1-phosphate results in increased expression of LAMC2 mRNA |
CTD |
PMID:15541073 |
|
NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of MAP1LC3B mRNA]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein]; sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein sphingosine 1-phosphate results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:37169277 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK1 protein]; Plant Extracts inhibits the reaction [sphingosine 1-phosphate results in increased activity of and results in increased phosphorylation of MAPK1 protein]; sphingosine 1-phosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein; Suramin inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK1 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK1 protein modified form |
CTD |
PMID:16365044 PMID:18612546 PMID:22251058 PMID:22406263 PMID:26518876 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK3 protein]; Plant Extracts inhibits the reaction [sphingosine 1-phosphate results in increased activity of and results in increased phosphorylation of MAPK3 protein]; sphingosine 1-phosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein; Suramin inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of MAPK3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of MAPK3 protein modified form |
CTD |
PMID:16365044 PMID:18612546 PMID:22251058 PMID:22406263 PMID:26518876 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions increases expression |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP2 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP2 protein] sphingosine 1-phosphate results in increased expression of MMP2 mRNA; sphingosine 1-phosphate results in increased expression of MMP2 protein |
CTD |
PMID:26518876 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions increases expression |
EXP |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]; Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein]; Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]; Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein] sphingosine 1-phosphate results in increased expression of MMP9 mRNA; sphingosine 1-phosphate results in increased expression of MMP9 protein |
CTD |
PMID:25980589 PMID:26518876 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
ISO |
3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of NLRP3 protein]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [sphingosine 1-phosphate results in increased expression of NLRP3 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of NLRP3 mRNA]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of NLRP3 protein] |
CTD |
PMID:37169277 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
|
|
G |
NRP1 |
neuropilin 1 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP1 mRNA]; sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP1 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
|
|
G |
NRP2 |
neuropilin 2 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [N-acetylsphingosine results in decreased expression of NRP2 mRNA]; sphingosine 1-phosphate inhibits the reaction [Thalidomide results in decreased expression of NRP2 mRNA] |
CTD |
PMID:15741222 |
|
NCBI chr 2:205,682,501...205,798,131
Ensembl chr 2:205,681,990...205,798,133
|
|
G |
PECAM1 |
platelet and endothelial cell adhesion molecule 1 |
increases expression |
ISO |
sphingosine 1-phosphate results in increased expression of PECAM1 protein |
CTD |
PMID:19349368 |
|
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
|
|
G |
PLCB4 |
phospholipase C beta 4 |
increases expression multiple interactions |
EXP |
sphingosine 1-phosphate results in increased expression of PLCB4 protein Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of PLCB4 protein]; Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of PLCB4 protein] |
CTD |
PMID:25980589 |
|
NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Bezafibrate results in increased activity of PPARA protein] which results in decreased abundance of sphingosine 1-phosphate |
CTD |
PMID:18024222 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
dihydrosphingosine 1-phosphate inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; dihydrosphingosine 1-phosphate inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein]; JTE 013 inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein]; JTE 013 promotes the reaction [Suramin inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; Mevalonic Acid inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; MK 2206 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein]; S1PR2 mutant form inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; S1PR3 mutant form inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; sphingosine 1-phosphate inhibits the reaction [dihydrosphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; sphingosine 1-phosphate inhibits the reaction [dihydrosphingosine 1-phosphate results in increased expression of PTGS2 protein]; sphingosine 1-phosphate inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; sphingosine 1-phosphate inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 protein]; Suramin inhibits the reaction [Simvastatin promotes the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]]; Suramin inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]; Suramin promotes the reaction [JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA]] sphingosine 1-phosphate results in increased expression of PTGS2 mRNA; sphingosine 1-phosphate results in increased expression of PTGS2 protein |
CTD |
PMID:18612546 PMID:26518876 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate affects the localization of RELA protein modified form] |
CTD |
PMID:26518876 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
increases response to substance affects binding multiple interactions increases expression |
ISO EXP |
S1PR1 protein results in increased susceptibility to sphingosine 1-phosphate S1PR1 protein binds to sphingosine 1-phosphate S1PR1 protein affects the reaction [sphingosine 1-phosphate results in increased expression of IL1B mRNA] sphingosine 1-phosphate results in increased expression of S1PR1 mRNA sphingosine 1-phosphate binds to and results in increased activity of S1PR1 protein |
CTD |
PMID:20844107 PMID:24399507 PMID:32401414 PMID:35412894 |
|
NCBI chr 1:101,236,899...101,242,313
Ensembl chr 1:101,236,865...101,243,713
|
|
G |
S1PR2 |
sphingosine-1-phosphate receptor 2 |
multiple interactions increases expression increases uptake increases activity |
EXP ISO |
S1PR2 mutant form inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA] sphingosine 1-phosphate results in increased expression of S1PR2 protein sphingosine 1-phosphate results in increased uptake of S1PR2 protein sphingosine 1-phosphate results in increased activity of S1PR2 protein [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [sphingosine 1-phosphate results in increased expression of FN1 protein]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] results in decreased susceptibility to [sphingosine 1-phosphate co-treated with Glucose]; [JTE 013 binds to and results in decreased activity of S1PR2 protein] which results in decreased susceptibility to sphingosine 1-phosphate; [sphingosine 1-phosphate results in increased activity of S1PR2 protein] which results in increased expression of FN1; JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR2 protein]; sphingosine 1-phosphate promotes the reaction [dibutyldichlorotin results in increased expression of S1PR2 protein] |
CTD |
PMID:18612546 PMID:22406263 PMID:26518876 PMID:37169277 |
|
NCBI chr19:10,221,433...10,231,331
Ensembl chr19:10,221,433...10,231,331
|
|
G |
S1PR3 |
sphingosine-1-phosphate receptor 3 |
multiple interactions increases expression |
EXP |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR3 protein]; Phytochemicals analog inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR3 protein]; S1PR3 mutant form inhibits the reaction [sphingosine 1-phosphate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:18612546 PMID:25980589 |
|
NCBI chr 9:88,990,863...89,005,155
Ensembl chr 9:88,990,863...89,005,155
|
|
G |
S1PR5 |
sphingosine-1-phosphate receptor 5 |
multiple interactions |
EXP |
Endocannabinoids inhibits the reaction [sphingosine 1-phosphate binds to and results in increased activity of S1PR5 protein]; sphingosine 1-phosphate binds to and results in increased activity of S1PR5 protein |
CTD |
PMID:30102254 |
|
NCBI chr19:10,512,742...10,517,965
Ensembl chr19:10,512,742...10,517,931
|
|
G |
SMAD3 |
SMAD family member 3 |
increases phosphorylation |
ISO |
sphingosine 1-phosphate results in increased phosphorylation of SMAD3 protein |
CTD |
PMID:37169277 |
|
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
|
|
G |
SMPD2 |
sphingomyelin phosphodiesterase 2 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [Thalidomide results in increased activity of SMPD2 protein] |
CTD |
PMID:15741222 |
|
NCBI chr 6:109,440,724...109,443,919
Ensembl chr 6:109,440,724...109,443,919
|
|
G |
SPHK1 |
sphingosine kinase 1 |
increases chemical synthesis multiple interactions |
EXP |
SPHK1 protein results in increased chemical synthesis of sphingosine 1-phosphate [Resveratrol affects the localization of and results in decreased activity of SPHK1 protein] which results in decreased abundance of sphingosine 1-phosphate; sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SPHK1 mRNA]; sphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SPHK1 protein] |
CTD |
PMID:22251058 PMID:24399507 PMID:26045781 |
|
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
|
|
G |
SPNS2 |
SPNS lysolipid transporter 2, sphingosine-1-phosphate |
increases secretion multiple interactions |
EXP |
SPNS2 protein results in increased secretion of sphingosine 1-phosphate TGFB2 protein promotes the reaction [SPNS2 protein results in increased secretion of sphingosine 1-phosphate] |
CTD |
PMID:29772789 |
|
NCBI chr17:4,498,881...4,539,035
Ensembl chr17:4,498,881...4,539,035
|
|
G |
SQSTM1 |
sequestosome 1 |
decreases expression |
ISO |
sphingosine 1-phosphate results in decreased expression of SQSTM1 protein |
CTD |
PMID:37169277 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions increases phosphorylation |
EXP |
Janus Kinase Inhibitors inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of STAT3 protein]; STAT3 protein affects the reaction [sphingosine 1-phosphate results in increased expression of IL1B mRNA]; STAT3 protein affects the reaction [sphingosine 1-phosphate results in increased secretion of IL1B protein] |
CTD |
PMID:32401414 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TGFB2 |
transforming growth factor beta 2 |
multiple interactions |
EXP |
TGFB2 protein promotes the reaction [SPNS2 protein results in increased secretion of sphingosine 1-phosphate] |
CTD |
PMID:29772789 |
|
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of TNF mRNA]; sphingosine 1-phosphate inhibits the reaction [TNF results in increased expression of VCAM1] |
CTD |
PMID:18981156 PMID:26518876 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
sphingosine 1-phosphate inhibits the reaction [TNF results in increased expression of VCAM1] |
CTD |
PMID:18981156 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|